Breadcrumb AMCP.org Resource Center Publications Letters, Statements & Analysis AMCP Comments on Regulatory Considerations for Prescription Drug Use-Related Software AMCP Comments on Regulatory Considerations for Prescription Drug Use-Related Software 12/18/23 Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page AMCP_Comment_Letter_Prescription_Drug_Use_Related_Software_12.18.23.pdf Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page